source Post navigation Novo Nordisk A/S: CagriSema demonstrates superior weight loss in adults with obesity or overweight and type 2 diabetes in the REDEFINE 2 trial – Yahoo Finance What Are the Treatment Guidelines for Children with Type 1 Diabetes? – Healthline
